PMID- 15842956 OWN - NLM STAT- MEDLINE DCOM- 20050930 LR - 20220716 IS - 1529-7322 (Print) IS - 1529-7322 (Linking) VI - 5 IP - 3 DP - 2005 May TI - The immunoglobulin E receptor: expression and regulation. PG - 191-6 AB - The interaction of immunoglobulin E (IgE) and its receptors is critical for the manifestation of allergic disease. Currently, IgE receptors include the high-affinity Fc epsilonRI and the low-affinity Fc epsilonRII. Fc epsilonRI is a tetrameric or trimeric complex, and each has distinct expression patterns and unique functional consequences. In general, serum levels of IgE regulate Fc epsilonRI expression, and novel therapies that lower the concentration of IgE have provided insights into the contribution of this receptor in allergic disease. Newer therapies targeting Fc epsilonRI-signaling elements and the low-affinity IgE receptor, Fc epsilonRII (CD23), are being developed. FAU - Conner, Edward R AU - Conner ER AD - Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA. FAU - Saini, Sarbjit S AU - Saini SS LA - eng PT - Journal Article PT - Review PL - United States TA - Curr Allergy Asthma Rep JT - Current allergy and asthma reports JID - 101096440 RN - 0 (Antibodies, Anti-Idiotypic) RN - 0 (Antibodies, Monoclonal) RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Receptors, IgE) RN - 2P471X1Z11 (Omalizumab) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Animals MH - Antibodies, Anti-Idiotypic MH - Antibodies, Monoclonal/pharmacology MH - Antibodies, Monoclonal, Humanized MH - Antigen-Presenting Cells/metabolism MH - Basophils/metabolism MH - Dendritic Cells/metabolism MH - Eosinophils/metabolism MH - Humans MH - Hypersensitivity/immunology/*metabolism MH - Immunoglobulin E/blood/immunology/metabolism MH - Mast Cells/metabolism MH - Omalizumab MH - Receptors, IgE/*immunology/*metabolism RF - 47 EDAT- 2005/04/22 09:00 MHDA- 2005/10/01 09:00 CRDT- 2005/04/22 09:00 PHST- 2005/04/22 09:00 [pubmed] PHST- 2005/10/01 09:00 [medline] PHST- 2005/04/22 09:00 [entrez] AID - 10.1007/s11882-005-0037-5 [doi] PST - ppublish SO - Curr Allergy Asthma Rep. 2005 May;5(3):191-6. doi: 10.1007/s11882-005-0037-5.